SCHEMBL10569201

SCHEMBL10569201

Clc1ccc(Nc2ccncc2)c(Cl)c1

nearest known ligand 0.61

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
JAK2 O60674 2/20 0.50
JAK1 P23458 2/20 0.50
TYK2 P29597 2/20 0.50
ADRA2A P08913 1/20 0.50
KMT2A Q03164 6/20 0.49
MEN1 O00255 4/20 0.49
HTT P42858 2/20 0.48
LMNA P02545 2/20 0.48
MAPK1 P28482 1/20 0.47
PIK3CA P42336 2/20 0.46
PIK3CB P42338 2/20 0.46
PIK3CG P48736 2/20 0.46
ALDH1A1 P00352 2/20 0.46
GAA P10253 1/20 0.46
ALOX15 P16050 1/20 0.46
TDP1 Q9NUW8 1/20 0.46
HPGD P15428 1/20 0.46
TGFBR1 P36897 2/20 0.45
MAPT P10636 2/20 0.44
RAD52 P43351 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3714113 0.81 TDO2 (0.50) ADRA2AKMT2AMEN1HTTLMNA
SCHEMBL9631014 0.80 ALDH1A1 (0.69) HTTLMNAMAPK1ALDH1A1GAA
SCHEMBL11217909 0.77 GAA (0.54) HTTMAPK1ALDH1A1GAAALOX15
SCHEMBL5545978 0.77 ALDH1A1 (0.46) HTTMAPK1PIK3CAPIK3CBPIK3CG
SCHEMBL5640255 0.76 KMT2A (0.78) JAK2JAK1TYK2KMT2AMEN1
SCHEMBL10836320 0.76 GRIK1 (0.59) JAK2JAK1TYK2KMT2AMEN1
SCHEMBL10571549 0.76 ADRA2A (0.68) JAK2JAK1TYK2ADRA2AKMT2A
SCHEMBL10570649 0.74 KMT2A (0.61) ADRA2AKMT2AMEN1LMNAMAPK1
SCHEMBL9223214 0.73 ALDH1A1 (0.47) KMT2AMEN1HTTMAPK1ALDH1A1
SCHEMBL25168951 0.73 ADRA2A (0.58) ADRA2AKMT2AMEN1HTTLMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-4855308-A Method of treating senile cognitive decline with N'-substituted aminopyridine adrenergic agents WARNER-LAMBERT COMPANY (US) 1989-08-08 US claimed
US-4855308-A Method of treating senile cognitive decline with N'-substituted aminopyridine adrenergic agents WARNER-LAMBERT COMPANY (US) 1989-08-08 US disclosed